Literature DB >> 33902711

The role of the endogenous oxytocin system under psychosocial stress conditions in adolescents suffering from anxiety disorder: study protocol for a parallel group controlled trial.

Leonie Goetz1, Irina Jarvers1, Daniel Schleicher1, Kathrin Mikan1, Romuald Brunner1, Stephanie Kandsperger2.   

Abstract

BACKGROUND: In social neuroscience, the linkage between the endocrinological system and the etiology and symptomatology of mental health problems has received increasing attention. A particular focus is given to the neuropeptide oxytocin with its anxiolytic and stress-buffering effect and the resulting therapeutic potential for anxiety disorders. Even though anxiety disorders are the most prevalent mental health disorders in childhood and adolescence worldwide, the reactivity of the endogenous oxytocin system to an acute stressor (Trier Social Stress Test, TSST) has so far only been investigated in healthy children. It has been shown that peripheral oxytocin levels increased under psychosocial stress conditions. In the present study, it is hypothesized that the endogenous oxytocin system in children and adolescents suffering from a clinically diagnosed anxiety disorder is dysregulated. Three primary outcome parameters will be analyzed: significant differences between participants with anxiety disorders compared to healthy controls in basal oxytocin levels, varying salivary oxytocin release after stress exposure and the correlation between the cortisol peak/-decrease and oxytocin level over time. Secondary outcome criteria are significant differences in physiological (heart rate) and psychological (perceived stress, anxiety, insecurity, tension) responses.
METHODS: The present study is a single-center experimental observation study to investigate the reactivity of the endocrinological system to a psychosocial stressor (TSST). 32 children and adolescents (11-18 years) suffering from anxiety disorder will be compared to a matched healthy control group. After a detailed psychological assessment, saliva samples will be taken to measure oxytocin levels before and after psychosocial stress exposure at eight different time points. Additionally, the stress hormone cortisol will be analyzed according to the same procedure. DISCUSSION: Due to the high prevalence and comorbidity rate with numerous other psychiatric disorders and mental health problems, there is an urgent need to strengthen research in possible neurobiological underpinnings of anxiety disorders. To our knowledge, the proposed experiment is the first study to examine the endocrinological oxytocin and cortisol reaction to an acute psychosocial stressor in children and adolescents with mental health disorders. Trial registration The study is registered in the German Clinical Trials Register since 11 September 2019, DRKS00017793, https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00017793 .

Entities:  

Keywords:  Anxiety disorder; Case–control study; Children and adolescents; Cortisol; Oxytocin; Stress mechanisms; Trier social stress test

Year:  2021        PMID: 33902711     DOI: 10.1186/s40359-021-00564-z

Source DB:  PubMed          Journal:  BMC Psychol        ISSN: 2050-7283


  43 in total

1.  Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents.

Authors:  Guilherme V Polanczyk; Giovanni A Salum; Luisa S Sugaya; Arthur Caye; Luis A Rohde
Journal:  J Child Psychol Psychiatry       Date:  2015-02-03       Impact factor: 8.982

2.  Anxiety disorders in adolescents and psychosocial outcomes at age 30.

Authors:  Cecilia A Essau; Peter M Lewinsohn; Beatriz Olaya; John R Seeley
Journal:  J Affect Disord       Date:  2014-01-02       Impact factor: 4.839

Review 3.  The evidence-based pharmacotherapy of social anxiety disorder.

Authors:  Carlos Blanco; Laura B Bragdon; Franklin R Schneier; Michael R Liebowitz
Journal:  Int J Neuropsychopharmacol       Date:  2012-03-21       Impact factor: 5.176

4.  Patterns of junctional communication in the early amphibian embryo.

Authors:  S C Guthrie
Journal:  Nature       Date:  1984 Sep 13-19       Impact factor: 49.962

Review 5.  Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review.

Authors:  Jeffrey R Strawn; Laura Geracioti; Neil Rajdev; Kelly Clemenza; Amir Levine
Journal:  Expert Opin Pharmacother       Date:  2018-07       Impact factor: 3.889

6.  Treatment gap for anxiety disorders is global: Results of the World Mental Health Surveys in 21 countries.

Authors:  Jordi Alonso; Zhaorui Liu; Sara Evans-Lacko; Ekaterina Sadikova; Nancy Sampson; Somnath Chatterji; Jibril Abdulmalik; Sergio Aguilar-Gaxiola; Ali Al-Hamzawi; Laura H Andrade; Ronny Bruffaerts; Graça Cardoso; Alfredo Cia; Silvia Florescu; Giovanni de Girolamo; Oye Gureje; Josep M Haro; Yanling He; Peter de Jonge; Elie G Karam; Norito Kawakami; Viviane Kovess-Masfety; Sing Lee; Daphna Levinson; Maria Elena Medina-Mora; Fernando Navarro-Mateu; Beth-Ellen Pennell; Marina Piazza; José Posada-Villa; Margreet Ten Have; Zahari Zarkov; Ronald C Kessler; Graham Thornicroft
Journal:  Depress Anxiety       Date:  2018-01-22       Impact factor: 6.505

7.  Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A).

Authors:  Kathleen Ries Merikangas; Jian-Ping He; Marcy Burstein; Sonja A Swanson; Shelli Avenevoli; Lihong Cui; Corina Benjet; Katholiki Georgiades; Joel Swendsen
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-07-31       Impact factor: 8.829

8.  [Mental health of children and adolescents in Germany. Results from the BELLA study within the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)].

Authors:  U Ravens-Sieberer; N Wille; S Bettge; M Erhart
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2007 May-Jun       Impact factor: 1.513

Review 9.  Pharmacotherapy for anxiety disorders in children and adolescents.

Authors:  Ian Kodish; Carol Rockhill; Chris Varley
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

10.  The utility of the SCAS-C/P to detect specific anxiety disorders among clinically anxious children.

Authors:  Tessa Reardon; Cathy Creswell; Kathryn J Lester; Kristian Arendt; Judith Blatter-Meunier; Susan M Bögels; Jonathan R I Coleman; Peter J Cooper; Einar R Heiervang; Chantal Herren; Sanne M Hogendoorn; Jennifer L Hudson; Robert Keers; Heidi J Lyneham; Carla E Marin; Maaike Nauta; Ronald M Rapee; Susanna Roberts; Silvia Schneider; Wendy K Silverman; Mikael Thastum; Kerstin Thirlwall; Gro Janne Wergeland; Thalia C Eley
Journal:  Psychol Assess       Date:  2019-05-09
View more
  1 in total

1.  Annexin-A1 deficiency attenuates stress-induced tumor growth via fatty acid metabolism in mice: an Integrated multiple omics analysis on the stress- microbiome-metabolite-epigenetic-oncology (SMMEO) axis.

Authors:  Jianzhou Cui; Karishma Sachaphibulkij; Wen Shiun Teo; Hong Meng Lim; Li Zou; Choon Nam Ong; Rudi Alberts; Jinmiao Chen; Lina H K Lim
Journal:  Theranostics       Date:  2022-05-09       Impact factor: 11.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.